KYMR Kymera Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 5, 2026
$107,39
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$55,26minimo 52 sett.
$130,05massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$8.89B
P/E (TTM)
-33.0
EPS (TTM)
$-3.25
Ricavi (TTM)
$105M
i tuoi badge
Intervallo 52 sett.
$55–$130
Rating Analisti
BUY
Prezzo Obiettivo
$139
P/E
-33.0
ROE
-24.2%
Margine di Profitto Netto
-285.3%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
KYMR Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$107.39
Capitalizzazione di Mercato (MRQ)
$8.89B
P/E (TTM)
-33.0
EPS (TTM)
$-3.25
Ricavi (TTM)
$105M
ROE (TTM)
-24.2%
Intervallo 52 sett.
$55–$130
KYMR Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Informazioni su Kymera Therapeutics, Inc. - Common Stock Panoramica della società da Wikipedia
settoreHealthcare
industriaBiotechnology
dipendenti273
paeseUS
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$39M2019-12-31 → 2025-12-31
EPS$-3.692020-12-31 → 2025-12-31
Flusso di cassa libero$-234M2020-12-31 → 2025-12-31
Margine netto-285.3%2020-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | KYMR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -33.0media 5 anni ≈-16.8 | ≈-16.8 | · | · | |
| P/S (TTM) | 84.7media 5 anni ≈72.8 | ≈72.8 | 58.4 | Sopravvalutato | |
| P/B (MRQ) | 5.9media 5 anni ≈4.3 | ≈4.3 | 7.6 | Sottovalutato | |
| Prezzo / FCF (TTM) | -37.4media 5 anni ≈-18.4 | ≈-18.4 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -37.6media 5 anni ≈-18.7 | ≈-18.7 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 5.5media 5 anni ≈4.3 | ≈4.3 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | KYMR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -333.5%media 5 anni ≈-428.0% | ≈-428.0% | -171.2% | Di prim'ordine | |
| Margine EBITDA (TTM) | -325.7%media 5 anni ≈-417.8% | ≈-417.8% | -167.1% | Di prim'ordine | |
| Pretax Margin (Margine ante imposte) | -794.0% | · | -116.7% | Debole | |
| Margine di Profitto Netto (TTM) | -285.3%media 5 anni ≈-385.0% | ≈-385.0% | -176.2% | Di prim'ordine | |
| ROA (TTM) | -21.6%media 5 anni ≈-24.1% | ≈-24.1% | -22.4% | Debole | |
| ROE (TTM) | -24.2%media 5 anni ≈-27.9% | ≈-27.9% | -20.3% | Debole | |
| ROIC | -22.1% | · | -22.1% | In linea |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | KYMR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 10.3media 5 anni ≈6.7 | ≈6.7 | 8.3 | Liquidità elevata | |
| Quick Ratio | 4.3media 5 anni ≈1.8 | ≈1.8 | 3.6 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | KYMR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | -16.7%media 5 anni ≈17.9% | ≈17.9% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | -5.7%media 5 anni ≈4.3% | ≈4.3% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 2.9% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | KYMR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.1 | ≈0.1 | 0.1 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$143.6K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.16%
Prossimo report
Nov 02, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 10, 2026 | $-0.62 | $-0.73 | 14.8% |
| 31 Marzo 2026 | $-0.71 | $-0.90 | 21.0% | |
| 31 Dicembre 2025 | $-0.97 | $-0.81 | -19.4% | |
| 30 Settembre 2025 | $-0.94 | $-0.82 | -14.6% | |
| 30 Giugno 2025 | $-0.95 | $-0.83 | -15.0% | |
| 31 Marzo 2025 | $-0.82 | $-0.93 | 12.3% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39M | $47M | $79M | $47M | $73M | $34M | $3M | |
| Cost of Revenue | $39M | $47M | $79M | $47M | · | · | · | |
| R&D Expense | $317M | $240M | $189M | $164M | $137M | $62M | $37M | |
| SG&A Expense | $68M | $64M | $55M | $44M | $36M | $18M | $8M | |
| Operating Expenses | $389M | $309M | $244M | $208M | $173M | $80M | $45M | |
| Operating Income | $-349M | $-262M | $-166M | $-161M | $-101M | $-46M | $-42M | |
| Other Non-op | $38M | $38M | $19M | $6M | $313.0K | $711.0K | $959.0K | |
| Pretax Income | $-311M | · | · | · | · | · | · | |
| Income Tax | $0 | · | · | $0 | $0 | $0 | $0 | |
| Net Income | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | $-41M | |
| EPS (Basic) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| EPS (Diluted) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| Shares (Basic) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| Shares (Diluted) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| EBITDA | $-341M | $-254M | $-162M | $-158M | $-98M | $-45M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $357M | $120M | $110M | $68M | $48M | $31M | $76M | |
| Receivables | $0 | $0 | $15M | $0 | · | · | · | |
| Prepaid Expense | $23M | $22M | $12M | $10M | $9M | $5M | $888.0K | |
| Current Assets | $871M | $510M | $405M | $419M | $451M | $302M | $93M | |
| PP&E (Net) | $43M | $50M | $48M | $13M | $12M | $11M | $4M | |
| PP&E (Gross) | $65M | $67M | $59M | $20M | $16M | $13M | $5M | |
| Accum. Depreciation | $22M | $16M | $10M | $7M | $4M | $2M | $1M | |
| Other Non-current Assets | $9M | $2M | $2M | $3M | $2M | $30.0K | $2M | |
| Total Assets | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Accounts Payable | $4M | $6M | $7M | $4M | $4M | $4M | $3M | |
| Accrued Liabilities | $42M | $35M | $34M | $28M | $23M | $10M | $5M | |
| Current Liabilities | $83M | $68M | $86M | $71M | $93M | $111M | $35M | |
| Capital Leases | $67M | $72M | $77M | $12M | $13M | $14M | $17M | |
| Other Non-current Liabilities | · | $0 | $0 | $248.0K | $66.0K | $100.0K | · | |
| Total Liabilities | $163M | $142M | $181M | $113M | $146M | $203M | $82M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | · | |
| Retained Earnings | $-1.07B | $-755M | $-531M | $-384M | $-229M | $-129M | $-76M | |
| AOCI | $2M | $-1M | $-552.0K | $-5M | $-660.0K | $-128.0K | $6.0K | |
| Stockholders' Equity | $1.58B | $836M | $395M | $490M | $460M | $284M | $-74M | |
| Liabilities + Equity | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Shares Outstanding | 81,323,532 | 64,890,193 | 55,585,305 | 55,039,380 | 51,536,181 | 44,482,186 | 1,929,516 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $4M | $3M | $2M | $2M | $825.0K | |
| Stock-based Comp | $60M | $55M | $43M | $35M | $25M | $5M | $1M | |
| Other Non-cash | $10M | $-33M | $-3M | $-37M | $-56M | $127M | · | |
| Operating Cash Flow | $-233M | $-195M | $-103M | $-153M | $-129M | $88M | $18M | |
| CapEx | $1M | $13M | $34M | $3M | $2M | $9M | $532.0K | |
| Investing Cash Flow | $-521M | $-404M | $140M | $21M | $-100M | $-423M | $-16M | |
| Financing Cash Flow | $991M | $609M | $4M | $153M | $250M | $289M | $35M | |
| Net Change in Cash | $237M | $10M | $41M | $20M | $21M | $-45M | $36M | |
| Free Cash Flow | $-234M | $-207M | $-137M | $-156M | $-131M | $79M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% | -136.1% | · | |
| Net Margin | -794.0% | -475.6% | -187.0% | -330.6% | -137.6% | -134.0% | · | |
| Pretax Margin | -794.0% | · | · | · | · | · | · | |
| EBITDA Margin | -869.9% | -540.2% | -206.1% | -338.0% | -134.7% | -130.9% | · | |
| ROA | -22.9% | -28.8% | -24.9% | -25.6% | -18.3% | -15.1% | · | |
| ROE | -24.4% | -25.9% | -37.2% | -30.9% | -21.3% | -15.8% | · | |
| ROIC | -22.1% | · | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 | 2.7 | · | |
| Quick Ratio | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 | 0.3 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | 6.3 | 10.5 | · | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $19.42 | $12.88 | · | $8.91 | $8.92 | $6.38 | · | |
| Revenue / Share | $0.46 | $0.63 | $1.35 | $0.87 | · | · | · | |
| Cash Flow / Share | $-2.76 | $-2.59 | $-1.76 | $-2.84 | · | · | · | |
| Cash / Share | $4.39 | $1.85 | · | $1.24 | $0.93 | $0.70 | · | |
| EPS (TTM) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -16.7% | -40.1% | 67.8% | -35.7% | 114.0% | · | · | |
| Revenue CAGR 3Y | -5.7% | -13.5% | 32.2% | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $39M | $47M | $79M | $47M | $73M | $34M | · | |
| Net Income TTM | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | · | |
| Market Cap | $6.33B | $2.61B | · | $1.37B | $3.27B | $2.76B | · | |
| P/E | -21.1 | -13.5 | -10.1 | -8.7 | -30.4 | -19.7 | · | |
| P/S | 161.4 | 55.5 | · | 29.3 | 44.9 | 81.0 | · | |
| P/B | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Tangible Book | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Cash Flow | -27.2 | -13.4 | · | -9.0 | -25.4 | 31.3 | · | |
| P / FCF | -27.0 | -12.6 | · | -8.8 | -25.1 | 34.9 | · | |
| Earnings Yield | -4.7% | -7.4% | -9.9% | -11.5% | -3.3% | -5.1% | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | $48M | $5M | $17M | $9M | $16M | $10M | |
| Cost of Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | · | · | · | · | · | · | |
| R&D Expense | $119M | $98M | $84M | $74M | $78M | $80M | $72M | $60M | $59M | $49M | $53M | $48M | $46M | $42M | $43M | $44M | |
| SG&A Expense | $21M | $20M | $17M | $17M | $18M | $16M | $16M | $15M | $17M | $14M | $14M | $14M | $14M | $13M | $12M | $11M | |
| Operating Expenses | $141M | $119M | $101M | $95M | $96M | $97M | $88M | $76M | $77M | $68M | $67M | $62M | $60M | $55M | $55M | $54M | |
| Operating Income | $-76M | $-84M | $-98M | $-93M | $-85M | $-74M | $-81M | $-72M | $-51M | $-58M | $-19M | $-58M | $-43M | $-45M | $-39M | $-45M | |
| Other Non-op | $14M | $15M | $11M | $10M | $8M | $9M | $10M | $10M | $9M | $9M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $0 | · | $0 | |
| Net Income | $-61M | $-69M | $-87M | $-82M | $-77M | $-66M | $-71M | $-62M | $-42M | $-49M | $-14M | $-53M | $-39M | $-41M | $-35M | $-43M | |
| EPS (Basic) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| EPS (Diluted) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| Shares (Basic) | 98,177,158 | 97,534,269 | · | 87,300,286 | 80,449,405 | 80,146,531 | · | 76,125,975 | 73,059,398 | 70,770,320 | · | 58,421,859 | 58,326,963 | 58,187,038 | · | 54,535,514 | |
| Shares (Diluted) | 98,177,158 | 97,534,269 | · | 87,300,286 | 80,449,405 | 80,146,531 | · | 76,125,975 | 73,059,398 | 70,770,320 | · | 58,421,859 | 58,326,963 | 58,187,038 | · | 54,535,514 | |
| EBITDA | $-76M | $-82M | · | $-93M | $-85M | $-72M | · | $-72M | $-51M | $-56M | · | $-58M | $-43M | $-44M | · | $-45M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $124M | $144M | $357M | $113M | $336M | $90M | $120M | $111M | $68M | $94M | $110M | $81M | $52M | $50M | $68M | $156M | |
| Receivables | $20M | · | · | · | $40M | · | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $26M | $27M | $23M | $23M | $23M | $18M | $22M | $17M | $14M | $15M | · | $14M | $14M | $11M | · | $9M | |
| Current Assets | $737M | $677M | $871M | $528M | $728M | $501M | $510M | $569M | $525M | $537M | · | $376M | $385M | $412M | · | $494M | |
| PP&E (Net) | $40M | $42M | $43M | $45M | $49M | $49M | $50M | $51M | $52M | $49M | · | $36M | $27M | $17M | · | $13M | |
| PP&E (Gross) | $66M | $66M | $65M | $67M | $69M | $67M | $67M | $65M | $64M | $60M | · | $46M | $36M | $25M | · | $19M | |
| Accum. Depreciation | $26M | $24M | $22M | $22M | $20M | $18M | $16M | $14M | $12M | $11M | · | $10M | $9M | $8M | · | $6M | |
| Other Non-current Assets | $7M | $8M | $9M | $7M | $5M | $3M | $2M | $0 | $2M | $2M | · | $3M | $3M | $3M | · | $3M | |
| Total Assets | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Accounts Payable | $9M | $13M | $4M | $6M | $6M | $10M | $6M | $6M | $7M | $7M | · | $5M | $4M | $6M | · | $6M | |
| Accrued Liabilities | $48M | $35M | $42M | $29M | $28M | $23M | $35M | $27M | $24M | $16M | · | $26M | $22M | $19M | · | $25M | |
| Current Liabilities | $71M | $63M | $83M | $72M | $88M | $59M | $68M | $67M | $62M | $56M | · | $63M | $55M | $62M | · | $91M | |
| Capital Leases | $64M | $66M | $67M | $68M | $70M | $71M | $72M | $74M | $75M | $76M | · | $77M | $71M | $64M | · | $12M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $8.0K | $230.0K | $237.0K | · | $256.0K | |
| Total Liabilities | $136M | $129M | $163M | $156M | $160M | $132M | $142M | $142M | $141M | $157M | · | $157M | $147M | $152M | · | $126M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $-1.20B | $-1.14B | $-1.07B | $-979M | $-897M | $-820M | $-755M | $-684M | $-621M | $-579M | · | $-516M | $-464M | $-425M | · | $-349M | |
| AOCI | $-7M | $-4M | $2M | $2M | $279.0K | $-58.0K | $-1M | $2M | $-2M | $-2M | · | $-2M | $-4M | $-3M | · | $-6M | |
| Stockholders' Equity | $1.51B | $1.54B | $1.58B | $946M | $971M | $786M | $836M | $893M | $685M | $711M | $395M | $396M | $435M | $462M | $490M | $513M | |
| Liabilities + Equity | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Shares Outstanding | 82,788,253 | 82,182,101 | 81,323,532 | 71,741,174 | 70,557,442 | 65,112,714 | 64,890,193 | 64,748,226 | 61,572,383 | 61,353,146 | · | 55,450,239 | 55,390,259 | 55,276,226 | · | 54,751,429 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $891.0K | $895.0K | $900.0K | $879.0K | $818.0K | $767.0K | |
| Stock-based Comp | $19M | $16M | $14M | $16M | $15M | $14M | $14M | $15M | $14M | $12M | $11M | $12M | $11M | $9M | $9M | $9M | |
| Other Non-cash | · | $-38M | · | · | · | $-30M | · | · | · | $-4M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $-54M | $-89M | $-67M | $-27M | $-60M | $-79M | $-62M | $-50M | $-43M | $-40M | $8M | $-32M | $-35M | $-44M | $-40M | $-34M | |
| CapEx | $473.0K | $434.0K | $106.0K | $181.0K | $695.0K | $467.0K | $936.0K | $-189.0K | $5M | $7M | $12M | $8M | $11M | $4M | $373.0K | $1M | |
| Investing Cash Flow | $20M | $-143M | $-394M | $-235M | $60M | $49M | $69M | $-158M | $16M | $-331M | $19M | $61M | $36M | $25M | $-50M | $-37M | |
| Financing Cash Flow | $14M | $19M | $705M | $40M | $246M | $258.0K | $3M | $251M | $1M | $354M | $2M | $-206.0K | $1M | $1M | $2M | $150M | |
| Net Change in Cash | $-20M | $-213M | $244M | $-223M | $246M | $-30M | $10M | $43M | $-26M | $-16M | $29M | $29M | $2M | $-18M | $-87M | $79M | |
| Free Cash Flow | · | $-89M | · | · | · | $-80M | · | · | · | $-47M | · | · | · | $-48M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -116.3% | -244.9% | · | -3347.4% | -736.8% | -336.8% | · | -1927.9% | -198.5% | -562.2% | · | -1216.4% | -262.7% | -478.8% | · | -469.9% | |
| Net Margin | -94.2% | -201.5% | · | -2973.0% | -667.6% | -296.8% | · | -1670.3% | -164.0% | -472.0% | · | -1118.2% | -235.0% | -432.4% | · | -450.2% | |
| EBITDA Margin | -116.3% | -239.0% | · | -3347.4% | -736.8% | -327.5% | · | -1927.9% | -198.5% | -548.0% | · | -1216.4% | -262.7% | -469.5% | · | -469.9% | |
| ROA | -4.4% | -5.3% | · | -7.7% | -7.8% | -7.3% | · | -7.9% | -6.0% | -6.6% | · | -8.9% | -7.0% | -7.0% | · | -6.7% | |
| ROE | -4.9% | -5.9% | · | -8.9% | -9.2% | -8.8% | · | -9.7% | -7.5% | -8.3% | · | -11.6% | -9.3% | -9.2% | · | -8.6% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 10.8 | · | 7.4 | 8.3 | 8.5 | · | 8.5 | 8.5 | 9.6 | · | 5.9 | 7.1 | 6.6 | · | 5.4 | |
| Quick Ratio | 2.0 | 2.3 | · | 1.6 | 4.3 | 1.5 | · | 1.7 | 1.1 | 1.7 | · | 1.3 | 1.0 | 0.8 | · | 1.7 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 2.2 | · | · | · | 0.6 | · | · | · | · | · | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $18.23 | $18.73 | · | $13.19 | $13.77 | $12.07 | · | $13.79 | $11.12 | $11.59 | · | $7.13 | $7.86 | $8.36 | · | $9.37 | |
| Revenue / Share | $0.66 | $0.35 | · | $0.03 | $0.14 | $0.28 | · | $0.05 | $0.35 | $0.15 | · | $0.08 | $0.28 | $0.16 | · | $0.18 | |
| Cash Flow / Share | · | $-0.91 | · | · | · | $-0.99 | · | · | · | $-0.56 | · | · | · | $-0.76 | · | · | |
| Cash / Share | $1.50 | $1.75 | · | $1.57 | $4.76 | $1.38 | · | $1.71 | $1.10 | $1.52 | · | $1.46 | $0.95 | $0.91 | · | $2.84 | |
| EPS (TTM) | $-3.25 | $-3.58 | · | $-3.60 | $-3.48 | $-3.11 | · | $-2.34 | $-2.42 | $-2.51 | · | $-2.86 | $-2.75 | $-2.86 | · | $-2.95 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $105M | $51M | · | $44M | $45M | $59M | · | $88M | $89M | $79M | · | $47M | $52M | $47M | · | $46M | |
| Net Income TTM | $-300M | $-315M | · | $-295M | $-275M | $-241M | · | $-167M | $-158M | $-155M | · | $-167M | $-158M | $-159M | · | $-154M | |
| Market Cap | $9.49B | $6.84B | · | $4.06B | $3.08B | $1.78B | · | $3.06B | $1.84B | $2.47B | · | $771M | $1.27B | $1.64B | · | $1.19B | |
| P/E | -35.3 | -23.3 | · | -15.7 | -12.5 | -8.8 | · | -20.2 | -12.3 | -16.0 | · | -4.9 | -8.4 | -10.4 | · | -7.4 | |
| P/S | 90.4 | 133.0 | · | 92.8 | 68.9 | 30.3 | · | 35.0 | 20.8 | 31.1 | · | 16.5 | 24.6 | 35.1 | · | 25.9 | |
| P/B | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Tangible Book | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Cash Flow | · | -77.0 | · | · | · | -22.5 | · | · | · | -62.3 | · | · | · | -37.3 | · | · | |
| Earnings Yield | -2.8% | -4.3% | · | -6.4% | -8.0% | -11.4% | · | -4.9% | -8.1% | -6.2% | · | -20.6% | -12.0% | -9.7% | · | -13.6% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $39M | $47M | $79M | $47M | $73M |
| Margine Operativo % | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% |
| Utile netto | $-311M | $-224M | $-147M | $-155M | $-100M |
| EPS Diluito | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 |
| Quick Ratio | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-234M | $-207M | $-137M | $-156M | $-131M |
Proprietari istituzionali (13F) 305 filer · $10.2B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
305
Valore detenuto
$10.2B
Nuove posizioni
53
Posizioni chiuse
23
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 53 (+7 vs trimestre precedente) | 23 (-13 vs trimestre precedente) | 101 (+5 vs trimestre precedente) | 80 (+8 vs trimestre precedente) | +431K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| FMR LLC | $1.416.089.213 | 12.349.256 | 13,95% | Azioni |
| BAKER BROS. ADVISORS LP | $992.725.940 | 8.657.242 | 9,78% | Azioni |
| Avoro Capital Advisors LLC | $857.129.238 | 7.474.747 | 8,44% | Azioni |
| BlackRock, Inc. | $635.066.535 | 5.538.210 | 6,25% | Azioni |
| VANGUARD GROUP INC | $487.685.380 | 6.267.644 | 4,80% | Azioni |
| BVF INC/IL | $444.008.203 | 3.872.052 | 4,37% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $421.415.461 | 3.675.028 | 4,15% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $343.114.771 | 2.992.193 | 3,38% | Azioni |
| Siren, L.L.C. | $336.651.626 | 2.935.830 | 3,32% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $336.255.785 | 2.932.378 | 3,31% | Azioni |
| Atlas Venture Life Science Advisors, LLC | $326.527.526 | 2.847.541 | 3,22% | Azioni |
| STATE STREET CORP | $313.877.705 | 2.737.226 | 3,09% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $208.316.264 | 1.816.331 | 2,05% | Azioni |
| Capital Research Global Investors | $159.262.984 | 1.388.881 | 1,57% | Azioni |
| GOLDMAN SACHS GROUP INC | $136.151.475 | 1.187.333 | 1,34% | Azioni |
| UBS Group AG | $115.561.789 | 1.007.777 | 1,14% | Azioni |
| Driehaus Capital Management LLC | $105.408.448 | 919.233 | 1,04% | Azioni |
| Merck & Co., Inc. | $88.544.161 | 772.165 | 0,87% | Azioni |
| NORGES BANK | $86.833.399 | 757.246 | 0,86% | Azioni |
| FEDERATED HERMES, INC. | $85.933.469 | 749.398 | 0,85% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $85.421.500 | 745.152 | 0,84% | Azioni |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84.955.104 | 740.866 | 0,84% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $81.750.884 | 981.521 | 0,81% | Azioni |
| Holocene Advisors, LP | $72.996.514 | 636.579 | 0,72% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $72.951.379 | 875.872 | 0,72% | Azioni |
| NORTHERN TRUST CORP | $66.727.276 | 581.907 | 0,66% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60.744.024 | 529.729 | 0,60% | Azioni |
| FRANKLIN RESOURCES INC | $59.060.783 | 515.050 | 0,58% | Azioni |
| EVENTIDE ASSET MANAGEMENT, LLC | $57.811.287 | 504.210 | 0,57% | Azioni |
| JENNISON ASSOCIATES LLC | $57.676.487 | 502.978 | 0,57% | Azioni |
| Woodline Partners LP | $57.434.534 | 500.868 | 0,57% | Azioni |
| Rock Springs Capital Management LP | $51.963.399 | 453.156 | 0,51% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $51.570.654 | 449.731 | 0,51% | Azioni |
| Boxer Capital Management, LLC | $49.204.897 | 429.100 | 0,48% | Azioni |
| Pictet Asset Management Holding SA | $44.984.008 | 395.540 | 0,44% | Azioni |
| BANK OF AMERICA CORP /DE/ | $43.378.055 | 378.286 | 0,43% | Azioni |
| BRAIDWELL LP | $43.363.951 | 378.163 | 0,43% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $43.100.784 | 375.868 | 0,42% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $42.585.457 | 371.374 | 0,42% | Azioni |
| Clearbridge Investments, LLC | $39.815.871 | 347.221 | 0,39% | Azioni |
| Octagon Capital Advisors LP | $35.547.700 | 310.000 | 0,35% | Azioni |
| Nextech Invest Ltd. | $31.981.004 | 278.896 | 0,31% | Azioni |
| Alyeska Investment Group, L.P. | $31.701.095 | 276.455 | 0,31% | Azioni |
| TD Asset Management Inc | $31.293.443 | 272.900 | 0,31% | Azioni |
| VOYA INVESTMENT MANAGEMENT LLC | $30.951.039 | 269.914 | 0,30% | Azioni |
| TWO SIGMA ADVISERS, LP | $29.085.378 | 373.800 | 0,29% | Azioni |
| Commodore Capital LP | $28.667.500 | 250.000 | 0,28% | Azioni |
| RTW INVESTMENTS, LP | $27.520.800 | 240.000 | 0,27% | Azioni |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $26.799.869 | 233.713 | 0,26% | Azioni |
| GILDER GAGNON HOWE & CO LLC | $26.265.508 | 229.053 | 0,26% | Azioni |
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N, Hrustanovic Gorjan ×2 depositi | 26 Giugno 2026 | 6,30% | Modifica | · | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×4 depositi | 11 Dicembre 2025 | 10,90% | Modifica | Struttura del capitale | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×5 depositi | 09 Gennaio 2024 | · | Deposito iniziale | · | SEC |
| Vertex Pharmaceuticals Incorporated ×2 depositi | 05 Giugno 2023 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 25 insider · 10 dirigenti · 13 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Nello Mainolfi | Chief Executive Officer | 01 Ottobre 2026 M | 666.568 | 0 | 26 | $-36.819.541 |
| Bruce N. Jacobs | Chief Financial Officer | 30 Giugno 2026 M | 244.883 | 0 | 15 | $-9.956.105 |
| Jeremy G Chadwick | Chief Operating Officer | 27 Maggio 2026 S | 44.018 | 0 | 29 | $-15.599.618 |
| Brian Adams | Chief Legal Officer | 04 Settembre 2026 S | 50.254 | 0 | 3 | $-744.297 |
| Terence Rooney | Chief Medical Officer | 27 Luglio 2026 A | 38.000 | 0 | 0 | $0 |
| Noah Goodman | Chief Business Officer | 01 Luglio 2026 S | 47.179 | 0 | 9 | $-2.223.845 |
| Jared Gollob | Chief Medical Officer | 02 Marzo 2026 A | 117.134 | 0 | 18 | $-9.134.491 |
| Ellen Chiniara | Chief Legal Officer | 03 Marzo 2025 A | 80.085 | 0 | 0 | $0 |
| Elaine Caughey | Chief Business Officer | 01 Marzo 2023 A | 18.986 | 0 | 0 | $0 |
| Richard Chesworth | Chief Scientific Officer | 27 Agosto 2021 M | 0 | 0 | 0 | $0 |
| Bruce Booth | Direttore | 29 Giugno 2026 S | 462.856 | 0 | 160 | $-226.031.370 |
| Hrustanovic Gorjan | Direttore | 24 Giugno 2026 A | · | 0 | 0 | $0 |
| Elena Ridloff | Direttore | 24 Giugno 2026 A | 0 | 0 | 4 | $-1.285.644 |
| Pamela Esposito | Direttore | 24 Giugno 2026 A | 1.000 | 0 | 12 | $-3.054.174 |
| Jeffrey W. Albers | Direttore | 24 Giugno 2026 A | 0 | 0 | 3 | $-744.757 |
| Victor Sandor | Direttore | 24 Giugno 2026 A | · | 0 | 0 | $0 |
| John Maraganore | Direttore | 24 Giugno 2026 A | · | 0 | 0 | $0 |
| Leigh Morgan | Direttore | 18 Giugno 2024 A | · | 0 | 0 | $0 |
| Joanna Horobin | Direttore | 07 Giugno 2024 M | 0 | 0 | 0 | $0 |
| Donald William Nicholson | Direttore | 15 Giugno 2022 A | · | 0 | 0 | $0 |
| Steven Edward Hall | Direttore | 25 Agosto 2020 C | 2.192.249 | 0 | 0 | $0 |
| Andrew Hedin | Direttore | 20 Agosto 2020 A | · | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | Proprietario del 10% | 18 Maggio 2021 J | 5.763.012 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Proprietario del 10% | 25 Agosto 2020 C | 959.211 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | Proprietario del 10% | 25 Agosto 2020 C | 467.932 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 49 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| HAPS · Harbor ETF Trust | 2,21% | 36.388 NS | 31 Luglio 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,75% | 45.819 SH | 02 Ottobre 2026 | Giornaliero |
| GURU · Global X Funds | 1,41% | 8.375 NS | 31 Luglio 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,90% | 43.133 NS | 31 Luglio 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,80% | 3.605 NS | 31 Luglio 2026 | N-PORT |
| IBB · iShares Trust | 0,62% | 543.907 SH | 11 Settembre 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,61% | 5.875 SH | 02 Ottobre 2026 | Giornaliero |
| ESSC · Strategy Shares | 0,44% | 1.522 NS | 31 Luglio 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,43% | 24.014 NS | 31 Luglio 2026 | N-PORT |
| IWO · iShares Trust | 0,40% | 487.324 SH | 11 Settembre 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,35% | 55.351 SH | 19 Agosto 2026 | Giornaliero |
| PWS · Pacer Funds Trust | 0,25% | 589 NS | 31 Luglio 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,25% | 2.092 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,24% | 1.600.729 SH | 11 Settembre 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,22% | 360.394 SH | 19 Agosto 2026 | Giornaliero |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 14.574 NS | 31 Luglio 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,21% | 871.540 SH | 19 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,21% | 29.987 NS | 31 Luglio 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,19% | 32.324 SH | 19 Agosto 2026 | Giornaliero |
| FFSM · FIDELITY COVINGTON TRUST | 0,18% | 25.352 NS | 31 Luglio 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,14% | 17.965 NS | 31 Luglio 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,13% | 7.208 NS | 31 Luglio 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,10% | 152.728 NS | 31 Luglio 2026 | N-PORT |
| ISCG · iShares Trust | 0,10% | 8.361 SH | 11 Settembre 2026 | Giornaliero |
| ESML · iShares Trust | 0,09% | 22.280 SH | 11 Settembre 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1.509.269 SH | 19 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 19.721 SH | 02 Ottobre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 726.357 SH | 19 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 9.461 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,08% | 134.854 SH | 19 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,07% | 21.341 NS | 31 Luglio 2026 | N-PORT |
| WSML · iShares Trust | 0,06% | 3.284 SH | 11 Settembre 2026 | Giornaliero |
| FBCG · FIDELITY COVINGTON TRUST | 0,05% | 31.560 NS | 31 Luglio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 113.415 NS | 31 Luglio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 5.280 NS | 31 Luglio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3.058 NS | 31 Luglio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 15.117 NS | 31 Luglio 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 2.447 NS | 31 Luglio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 2.089.726 SH | 19 Agosto 2026 | Giornaliero |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 49.584 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5.163 SH | 19 Agosto 2026 | Giornaliero |
| ITOT · iShares Trust | 0,01% | 81.928 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,01% | 17.103 SH | 11 Settembre 2026 | Giornaliero |
| ESGV · VANGUARD WORLD FUND | 0,01% | 13.837 SH | 19 Agosto 2026 | Giornaliero |
| DFUS · Dimensional ETF Trust | 0,00% | 9.292 NS | 31 Luglio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 151 NS | 31 Luglio 2026 | N-PORT |
| IWN · iShares Trust | · | 102.204 SH | 11 Settembre 2026 | Giornaliero |
| ISCB · iShares Trust | · | 2.398 SH | 11 Settembre 2026 | Giornaliero |
| ISCV · iShares Trust | · | 6.014 SH | 11 Settembre 2026 | Giornaliero |
KYMR Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 30 analisti
COMPRA
Target mediano
$135.50
+26,2%
10 33,3%
Acquisto forte
16 53,3%
Compra
4 13,3%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
22 analisti · 2026-10-04Target medio $138.64 +29,1%
← Sotto tutti i target
Prezzo attuale $107.39
Basso$111.00
Media$138.64
Alto$180.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | · |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | · |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | · |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | · |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | · |
| PCVX | $6.05B | -8.2 | · | · | -26.6% | · |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | · |
| PRAX | $7.43B | -21.9 | 249.5% | · | -47.3% | · |
| SYRE | $2.56B | 10.1 | -62.0% | · | -26.5% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 5, 2026